The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
-
J. Heart Lung Transplant. · Dec 2014
Comparative StudyAwake extracorporeal membrane oxygenation bridging for pulmonary retransplantation provides comparable results to elective retransplantation.
Lung retransplantation became an accepted treatment for bronchiolitis obliterans syndrome (BOS). However, the value of different bridging modalities for these patients is controversial. ⋯ Awake ECMO bridging for retransplantation provides comparable results to elective retransplantation.
-
J. Heart Lung Transplant. · Nov 2014
Centers for Disease Control "high-risk" donor status does not significantly affect recipient outcome after heart transplantation in children.
In 2004, the United Network for Organ Sharing (UNOS) added the label "high-risk donor" (HRD) for any organ donor who met the Centers for Disease Control (CDC) criteria for high-risk behavior for infection. The aim of this study was to calculate the rate of HRD graft use in heart transplantation in children and determine the differences in outcome from those who received standard-risk donor (SRD) grafts. ⋯ CDC HRD graft status does not appear to significantly affect recipient outcome after heart transplantation in children.
-
J. Heart Lung Transplant. · Oct 2014
Treatment with inotropes and related prognosis in acute heart failure: contemporary data from the Italian Network on Heart Failure (IN-HF) Outcome registry.
In the recent Italian Network on Heart Failure (IN-HF) Outcome registry, including 1,855 patients with acute heart failure (AHF), we reviewed the use of inotropes and their prognostic implication on in-hospital and 12-month mortality. ⋯ Inotropes were used in nearly 20% of the patient admitted for AHF, and this treatment was associated with a short-term to medium-term poor prognosis. An inappropriate use of inotropes in patients with normal to high SBP, and presumably preserved cardiac output, may have significantly contributed to affect the all-group outcome.
-
J. Heart Lung Transplant. · Oct 2014
Substance abuse at the time of left ventricular assist device implantation is associated with increased mortality.
Advanced heart failure teams are often faced with the decision of whether or not to offer a left ventricular assist device (LVAD) to patients who have end-stage heart failure and recent or ongoing substance abuse. The outcomes of these patients after LVAD implantation are unknown. ⋯ Active substance abuse in patients who received an LVAD was associated with increased mortality and overall poor outcomes. Larger scale data will be needed to confirm these findings and to inform decision-making in this population.